Berwind Private Equity

Berwind Private Equity is a family-run private equity and venture capital firm based in Harvard, Massachusetts, focusing on acquisitions and seed capital. The firm seeks to acquire 100 percent of operating companies, emphasizing long-term ownership. Its investment criteria include strong existing management willing to stay for at least three years, a non-union workforce, and a customer base primarily in developed markets, with no single customer contributing over 20% of revenue. Berwind typically targets companies headquartered in the U.S., preferably in the Northeast, with revenues between $5 million and $25 million, and demonstrates strong gross margins and EBIT margins. The firm is particularly interested in manufacturers of non-commodity products and generally holds investments for three to five years. As an internally funded entity, Berwind can quickly evaluate opportunities and is flexible in deal structures, distinguishing itself from traditional private equity firms.

David Berwind

Director of Acquisitions

Michael Berwind

President

Hope Chik

Director of Venture Investments

7 past transactions

MacuLogix

Series D in 2019
MacuLogix, Inc. specializes in the diagnosis, monitoring, and treatment of age-related macular degeneration (AMD), a leading cause of blindness. The company offers the AdaptDx, a fully automated dark adaptometer designed to aid eye care professionals in detecting and tracking AMD at its earliest stages, potentially up to three years before it becomes visible. This early detection capability allows for timely intervention, which can help prevent vision loss. MacuLogix markets its products through distributors in the United States and internationally, as well as online, to ensure accessibility for healthcare providers. Founded in 2008 and based in Harrisburg, Pennsylvania, MacuLogix is committed to leveraging the science of dark adaptation to combat preventable blindness associated with AMD.

Netra

Seed Round in 2016
Netra Systems Inc. develops an artificial intelligence technology that automatically analyzes and interprets the contents of images and videos. The company offers its technology for multi-camera object, event, and activity recognitions/detections; automatic scene summarizations; instant cross-camera search options; and cross-camera object tracking needs. It provides its products for applications in healthcare, military, customs and border security, retail, security/surveillance, etc. The company was founded in 2013 and is based in Vancouver, Canada.

MacuLogix

Series C in 2015
MacuLogix, Inc. specializes in the diagnosis, monitoring, and treatment of age-related macular degeneration (AMD), a leading cause of blindness. The company offers the AdaptDx, a fully automated dark adaptometer designed to aid eye care professionals in detecting and tracking AMD at its earliest stages, potentially up to three years before it becomes visible. This early detection capability allows for timely intervention, which can help prevent vision loss. MacuLogix markets its products through distributors in the United States and internationally, as well as online, to ensure accessibility for healthcare providers. Founded in 2008 and based in Harrisburg, Pennsylvania, MacuLogix is committed to leveraging the science of dark adaptation to combat preventable blindness associated with AMD.

Persimmon Technologies

Series B in 2014
Persimmon Technologies Corporation is a technology company based in Wakefield, Massachusetts, specializing in the development, manufacturing, and distribution of atmospheric and vacuum robotics, vacuum modules, and automation systems. Founded in 2010, the company serves key markets including semiconductor, data storage, LED, OLED, solar, and flat panel display equipment. Persimmon Technologies is recognized for its advanced vacuum robotics technology, which features superior mechanical design, control systems, and software capabilities compared to existing solutions. The company also acts as a sales representative for Nidec Sankyo Corporation's atmospheric robotic products in the United States and operates as a subsidiary of Sumitomo Heavy Industries, Ltd.

MacuLogix

Series A in 2013
MacuLogix, Inc. specializes in the diagnosis, monitoring, and treatment of age-related macular degeneration (AMD), a leading cause of blindness. The company offers the AdaptDx, a fully automated dark adaptometer designed to aid eye care professionals in detecting and tracking AMD at its earliest stages, potentially up to three years before it becomes visible. This early detection capability allows for timely intervention, which can help prevent vision loss. MacuLogix markets its products through distributors in the United States and internationally, as well as online, to ensure accessibility for healthcare providers. Founded in 2008 and based in Harrisburg, Pennsylvania, MacuLogix is committed to leveraging the science of dark adaptation to combat preventable blindness associated with AMD.

Tantaline

Series B in 2011
Tantaline is the world's leading producer of tantalum surface alloys for valves, fittings, instrumentation, and custom products in hot acid environments. Through their innovative tantalum vapor technology, they deliver the most corrosion resistant material commercially available today through the use of tantalum, one of the most corrosion resistant metals.

Tantaline

Venture Round in 2008
Tantaline is the world's leading producer of tantalum surface alloys for valves, fittings, instrumentation, and custom products in hot acid environments. Through their innovative tantalum vapor technology, they deliver the most corrosion resistant material commercially available today through the use of tantalum, one of the most corrosion resistant metals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.